Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Computational Biology Research Group Win Software Grant

The Oxford Invention Fund (OIF) has awarded Steve Taylor, Head of the Computational Biology Research Group, £27000 to build Zegami, a high throughput image centric analysis software tool, building on the HTML5 Pivot Viewer software (Taylor and Noble, 2014).
 
The OIF fund was devised to ensure that smart ideas will be developed to a stage where they can be transferred from the University to business.  It provides an opportunity for donors to support the development of technology in Oxford, and help secure the University’s innovative infrastructure.

Reference

Taylor S, Noble R. HTML5 PivotViewer: high-throughput visualization and querying of image data on the web. Bioinformatics. 2014 May 21. pii: btu349.

Tell us your news

Paper accepted?

Received an award?

Contact communications@imm.ox.ac.uk to feature your story.

Tell us about your paper

Recent stories

New technology helps decode the genetic changes behind disease

Researchers from the Milne, Hughes and Davies Groups have developed a new technology that can reveal new therapeutic targets from common genetic variants linked to disease.

A summer of science and engagement

This summer, researchers at the MRC WIMM have taken part in a variety of public engagement activities, leading a stand at Cheltenham Science Festival and welcoming students for the Institute's summer work experience programme.

WIMM Day 2026: connecting people, ideas and scientific discovery

On Tuesday 23rd June, the MRC WIMM community came together at Saïd Business School for the Institute's annual away day, sharing research, professional achievements and much more.

Kevin Rue-Albrecht to lead BioFAIR Pathfinder Project

Congratulations to Dr Kevin Rue-Albrecht, who has been selected as one of BioFAIR’s inaugural Pathfinder Projects.

Verena Korber receives CRUK Career Development Fellowship

Congratulations to Dr Verena Korber, who has been awarded a Career Development Fellowship from Cancer Research UK.

Oxford University spinout Dark Blue Therapeutics acquired to advance leukaemia treatment

Oxford University spinout Dark Blue Therapeutics has been acquired by global biotechnology company Amgen in a deal worth up to US$840 million, marking a major milestone for Oxford-led cancer research and innovation. The deal reflects years of collaborative, multidisciplinary work across the University and its partners to translate fundamental research into promising new medicines.